Home
October 2008 November 2008 December 2008
Su Mo Tu We Th Fr Sa
Week 44 1
Week 45 2 3 4 5 6 7 8
Week 46 9 10 11 12 13 14 15
Week 47 16 17 18 19 20 21 22
Week 48 23 24 25 26 27 28 29
Week 49 30

Auricular Acupuncture: A Novel Treatment For Vasomotor Symptoms Associated With Luteinizing-Hormone Releasing Hormone Agonist Treatment for Prostate Cancer - Abstract Show Comments PDF Print E-mail
  
Friday, 29 August 2008

Department of Urology, James Cook University Hospital, Middlesbrough, UK.

To evaluate the role of auricular acupuncture (AA) in men receiving luteinizing-hormone releasing hormone (LHRH) analogues for carcinoma of the prostate, as vasomotor symptoms can affect the quality of life in such men, and similar symptoms in postmenopausal women have been successfully treated with AA.

In all, 60 consecutive patients with prostate cancer and on LHRH agonist treatment (median age 74 years, range 58-83) consented to weekly AA for 10 weeks. The validated 'Measure Yourself Concerns and Well-being' questionnaire (a six-point scale to assess symptom severity) was used to assess concerns and well-being before and after treatment.

All men completed the treatment with no adverse events recorded, apart from transient exacerbation of symptoms in two men; 95% of patients reported a decrease in the severity of symptoms, from a mean 5.0 to 2.1 (Student's t-test, P < 0.01).

The symptomatic improvement was at levels comparable with that from pharmacotherapy, and cost analysis showed AA to be a viable alternative. Larger randomized studies are needed to fully evaluate AA against more conventional treatments, and these are planned.

Written by:
Harding C, Harris A, Chadwick D.   Are you the author?

Reference:
BJU Int. 2008 Aug 14. Epub ahead of print.
doi:10.1111/j.1464-410X.2008.07884.x

PubMed Abstract
PMID:18710455

 

UroToday.com Prostate Cancer Section

 

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 
< Prev   Next >